Canaccord analyst Derek Dley lowered the firm’s price target on Trulieve Cannabis to C$50 from C$54 and keeps a Buy rating on the shares.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TCNNF: